Baolingbao Biology Co.,Ltd. (SHE:002286)
10.42
-0.09 (-0.86%)
At close: Feb 13, 2026
Baolingbao Biology Market Cap
Baolingbao Biology has a market cap or net worth of 3.97 billion as of February 13, 2026. Its market cap has increased by 37.67% in one year.
Market Cap
3.97B
Enterprise Value
3.90B
Revenue
2.69B
Ranking
n/a
PE Ratio
26.68
Stock Price
10.42
Market Cap Chart
Since August 28, 2009, Baolingbao Biology's market cap has increased from 1.81B to 3.97B, an increase of 119.50%. That is a compound annual growth rate of 4.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.97B | 16.55% |
| Dec 31, 2025 | 3.40B | 24.68% |
| Dec 31, 2024 | 2.73B | -9.36% |
| Dec 29, 2023 | 3.01B | -10.92% |
| Dec 30, 2022 | 3.38B | -32.78% |
| Dec 31, 2021 | 5.03B | 19.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Obio Technology (Shanghai) Corp. | 4.47B |
| Hinova Pharmaceuticals | 4.47B |
| Guanhao Biotech | 4.14B |
| Zhejiang Wecome Pharmaceutical Company | 4.12B |
| Zhejiang Shouxiangu Pharmaceutical | 4.10B |
| Boji Medical Technology | 4.05B |
| Shenzhen Bioeasy Biotechnology | 3.97B |
| Qingdao Vland Biotech INC. | 3.96B |